2002
New York, NY, and Santa Clara, CA - Clinsights Inc. today announced the launch of the Drug Eluting Stent Center (DESC) on TCTMD - the premier online community for interventional cardiologists and...
Guidant Awarded $158 Million In Damages Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, reported that an arbitration...
13 Percent Earnings Growth Leads to Earnings Per Share of $0.47, as Adjusted; Second Quarter Financial Guidance Reflects Enhanced Growth Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT),...
International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the SunTrust Robinson...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its first quarter 2002 earnings...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham has elected to move from her...
New position will have responsibility for Investor Relations, Corporate Communications, Corporate Marketing and Public Policy Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world...
Agreement with Novartis Pharma AG Broadens Guidant's Drug Eluting Stent Program Company to Host Webcast/Conference Call Today Indianapolis - Novartis Pharma AG and Guidant Corporation announced...
Guidant Announces FDA Approval of INSIGNIA Advanced Pacemaker and Comments on Heart Failure Therapy Filing Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Physicians Simulate New Interventional Procedure in a Virtual Environment Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Additional Stent Lengths, Improved Materials and Design Give Physicians More Options and Control Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader...
Company Creates Dedicated Peripheral Vascular Sales Organization Indianapolis, IN and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...
Wireless Telecommunication will Enable Internet Monitoring of Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular...
New Stabilizer Systems Designed to Make Procedure Available to More Patients Brussels, Belgium and Mainz, Germany - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company to Host Webcast/Conference Call Today Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today reported preliminary results of...
Clinical Trial Fully Enrolled In Less Than Four Months Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it has...
Innovative Lead Instrumental in Delivering Therapy for Heart Failure Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today issued the following statement on the status of its international ACTION...
New Stabilizer Systems Designed to Make Procedure Available to More Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...
Will Provide Physicians with a Cost-Effective, Non-Invasive Means to Monitor Aneurysm Pressure Indianapolis, Ind., Menlo Park, Calif., and Caesaria, Israel - Guidant Corporation (NYSE and PCX:...
Designed for Ease of Handling Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announces...
Presentation Accessible Via Webcast Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that Ronald W. Dollens,...
ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that the company has filed for CE...